Senile plaques in temporal lobe epilepsy - PubMed (original) (raw)

Comparative Study

doi: 10.1007/BF00294177.

Affiliations

• PMID: 8059603
• DOI: 10.1007/BF00294177

Comparative Study

Senile plaques in temporal lobe epilepsy

I R Mackenzie et al. Acta Neuropathol. 1994.

Abstract

Senile plaques (SP) are one of the characteristic pathological lesions of Alzheimer's disease (AD). They are also seen in the brains of some non-demented individuals as an age-related change. Identification of clinical conditions associated with these "incidental" SP could provide insight into AD pathogenesis. We have examined the presence of SP in lobectomy specimens (n = 101) removed in the surgical treatment of temporal lobe epilepsy (TLE). SP were present in 10 specimens from epileptic patients aged 36 to 61 years and the presence of SP correlated positively with patient age. No other significant AD-related pathology was identified and no patients showed any evidence of dementia on neuropsychological testing. When compared with temporal lobe tissue from non-demented, non-epileptic autopsy controls (n = 406), the density and distribution of SP was the same. The age-related incidence of SP however, was significantly greater in the epileptics. This suggests that some aspects of TLE has a positive influence on the formation of SP.

PubMed Disclaimer

Similar articles

• Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques.
  Mackenzie IR, McLachlan RS, Kubu CS, Miller LA. Mackenzie IR, et al. Neurology. 1996 Feb;46(2):425-9. doi: 10.1212/wnl.46.2.425. Neurology. 1996. PMID: 8614506
• Senile plaques do not progressively accumulate with normal aging.
  Mackenzie IR. Mackenzie IR. Acta Neuropathol. 1994;87(5):520-5. doi: 10.1007/BF00294179. Acta Neuropathol. 1994. PMID: 8059605
• Severity of cardiovascular disease, apolipoprotein E genotype, and brain pathology in aging and dementia.
  Alafuzoff I, Helisalmi S, Mannermaa A, Soininen H. Alafuzoff I, et al. Ann N Y Acad Sci. 2000 Apr;903:244-51. doi: 10.1111/j.1749-6632.2000.tb06374.x. Ann N Y Acad Sci. 2000. PMID: 10818513
• The neuropathological changes associated with normal brain aging.
  Hof PR, Glannakopoulos P, Bouras C. Hof PR, et al. Histol Histopathol. 1996 Oct;11(4):1075-88. Histol Histopathol. 1996. PMID: 8930649 Review.

Cited by

• BACE1 elevation is associated with aberrant limbic axonal sprouting in epileptic CD1 mice.
  Yan XX, Cai Y, Zhang XM, Luo XG, Cai H, Rose GM, Patrylo PR. Yan XX, et al. Exp Neurol. 2012 May;235(1):228-37. doi: 10.1016/j.expneurol.2012.01.003. Epub 2012 Jan 11. Exp Neurol. 2012. PMID: 22265658 Free PMC article.
• Regulation of astrocyte glutamine synthetase in epilepsy.
  Eid T, Tu N, Lee TS, Lai JC. Eid T, et al. Neurochem Int. 2013 Dec;63(7):670-81. doi: 10.1016/j.neuint.2013.06.008. Epub 2013 Jun 18. Neurochem Int. 2013. PMID: 23791709 Free PMC article. Review.
• Similar brain proteomic signatures in Alzheimer's disease and epilepsy.
  Leitner D, Pires G, Kavanagh T, Kanshin E, Askenazi M, Ueberheide B, Devinsky O, Wisniewski T, Drummond E. Leitner D, et al. Acta Neuropathol. 2024 Jan 30;147(1):27. doi: 10.1007/s00401-024-02683-4. Acta Neuropathol. 2024. PMID: 38289539 Free PMC article.
• Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.
  Marques MA, Crutcher KA. Marques MA, et al. J Mol Neurosci. 2003;20(3):327-37. doi: 10.1385/JMN:20:3:327. J Mol Neurosci. 2003. PMID: 14501016
• Role of Activated Glia and of Glial Cytokines in Alzheimer's Disease: A Review.
  Mrak RE, Griffin WS. Mrak RE, et al. EOS. 1996;16(3-4):80-84. EOS. 1996. PMID: 24478534 Free PMC article.

References

1. 1. Nature. 1988 Feb 11;331(6156):530-2 - PubMed
2. 1. Neurology. 1992 Sep;42(9):1681-8 - PubMed
3. 1. Acta Neuropathol. 1988;77(2):113-9 - PubMed
4. 1. Science. 1987 Feb 20;235(4791):880-4 - PubMed
5. 1. N Engl J Med. 1989 Jun 1;320(22):1446-52 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Other Literature Sources

  • The Lens - Patent Citations Database